Metropolitan Life Insurance CO Co Diagnostics, Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$7.16 - $9.56 $50 - $66	-7 Closed	0 $0
Q1 2021 Jun 26, 2023	BUY	$8.52 - $19.21 $60,935 - $137,389	7,152 New	7,152 $68.2 Million
Q1 2021 Mar 30, 2023	SELL	$8.52 - $19.21 $11,382 - $25,664	-1,336 Reduced 15.74%	7,152 $68,000
Q1 2021 May 14, 2021	SELL	$8.52 - $19.21 $72,258 - $162,920	-8,481 Reduced 99.92%	7 $68,000
Q4 2020 Jun 22, 2023	BUY	$9.3 - $15.19 $78,938 - $128,932	8,488 New	8,488 $78,000
Q3 2020 Jun 26, 2023	BUY	$8.24 - $30.8 $69,941 - $261,430	8,488 New	8,488 $115,000
Q2 2020 Jun 26, 2023	BUY	$7.46 - $23.42 $63,320 - $198,788	8,488 New	8,488 $164,000
Q2 2020 Mar 30, 2023	BUY	$7.46 - $23.42 $63,320 - $198,788	8,488 New	8,488 $164,000
Q2 2020 Aug 14, 2020	BUY	$7.46 - $23.42 $63,320 - $198,788	8,488 New	8,488 $164,000

5.59M

67.5K

174K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $12.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.